Rapport Net Debt vs Other Assets Analysis
| RAPP Stock | 20.25 0.25 1.22% |
Rapport Therapeutics, financial indicator trend analysis is much more than just breaking down Rapport Therapeutics, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rapport Therapeutics, is a good investment. Please check the relationship between Rapport Therapeutics, Net Debt and its Other Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rapport Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Net Debt vs Other Assets
Net Debt vs Other Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rapport Therapeutics, Net Debt account and Other Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Rapport Therapeutics,'s Net Debt and Other Assets is 0.96. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Other Assets in the same time period over historical financial statements of Rapport Therapeutics, Common, assuming nothing else is changed. The correlation between historical values of Rapport Therapeutics,'s Net Debt and Other Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Rapport Therapeutics, Common are associated (or correlated) with its Other Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Assets has no effect on the direction of Net Debt i.e., Rapport Therapeutics,'s Net Debt and Other Assets go up and down completely randomly.
Correlation Coefficient | 0.96 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Other Assets
Most indicators from Rapport Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rapport Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rapport Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. As of 12/11/2024, Enterprise Value is likely to grow to about 3.5 B, while Tax Provision is likely to drop 8,000.
| 2010 | 2023 | 2024 (projected) | Total Operating Expenses | 10.4M | 36.1M | 25.5M | Cost Of Revenue | 15K | 112K | 69.9K |
Rapport Therapeutics, fundamental ratios Correlations
Click cells to compare fundamentals
Rapport Therapeutics, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Rapport Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rapport Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving against Rapport Stock
| 0.44 | AKAN | Akanda Corp | PairCorr |
| 0.43 | TTOO | T2 Biosystms | PairCorr |
| 0.42 | AHG | Akso Health Group | PairCorr |
| 0.4 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.32 | CTLT | Catalent | PairCorr |
The ability to find closely correlated positions to Rapport Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rapport Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rapport Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rapport Therapeutics, Common to buy it.
The correlation of Rapport Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rapport Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rapport Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rapport Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Rapport Stock Analysis
When running Rapport Therapeutics,'s price analysis, check to measure Rapport Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rapport Therapeutics, is operating at the current time. Most of Rapport Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Rapport Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rapport Therapeutics,'s price. Additionally, you may evaluate how the addition of Rapport Therapeutics, to your portfolios can decrease your overall portfolio volatility.